Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus

Diseases of the Esophagus

Volumn 19, Issue 3, 2006, Pages 158-163

  Yano, M ^a   Takachi, K ^a   Doki, Y ^a   Miyashiro, I ^a   Kishi, K ^a   Noura, S ^a   Eguchi, H ^a   Yamada, T ^a   Ohue, M ^a   Ohigashi, H ^a   Sasaki, Y ^a   Ishikawa, O ^a   Imaoka, S ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Esophageal neoplasms; Histological effect; Lymphatic metastasis; Neoadjuvant chemotherapy; Squamous cell carcinoma

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOADJUVANT THERAPY; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33646774646     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00558.x     Document Type: Article

References (20)

1. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. Cancer 1992; 69: 1088-93.
2. Watanabe H, Kato K, Tachimori Y, Kise Y, Nakanishi Y, Ochiai A. Necessity of cervical lymph node dissection by retrospective analysis of submucosal cancer in mid- and lower thoracic esophagus. Ann Thorac Cardiovasc Surg 1995; 1: 49-53.
3. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-73.
4. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncol 1991; 48: 411-20.
5. The Registration Committee for Esophageal Cancer of JSDE. Comprehensive Registry of Esophageal Cancer in Japan. (1995,1996,1997), 2nd edn, Tokyo: The Japanese Society for Esophageal Diseases 2001.
6. Kato H, Tachimori Y, Watanabe H et al. Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol 1991; 48: 106-11.
7. Law S, Fok M, Chow S, Chu K M, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial. J Thorac Cardiovasc Surg 1997; 114: 210-17.
8. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002; 359: 1727-33.
9. Schlag P M. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 1992; 127: 1446-50.
10. Kelsen D P, Ginsberg R, Pajak T F et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979 -84.
11. Ancona E, Ruol A, Santi S et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91: 2165-74.
12. American Joint Committee on Cancer. Esophagus. In: Beahrs O H, Henson D E, Hutter R V, Kennedy B J (eds) Manual of Staging of Cancer, 4th edn. Philadelphia: JB Lippincott 1993, 75-9.
13. Wu L F, Wang B Z, Feng J L et al. Preoperative TN staging of esophageal cancer: Comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol 2003; 9: 219-24.
14. Kim K, Park S J, Kim B T, Lee K S, Shim Y M. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 2001; 71: 290-4.
15. Rasanen J V, Sihvo E I, Knuuti M J et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003; 10: 954-60.
16. Heidecke C D, Weighardt H, Feith M et al. Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy. Surgery 2002; 132: 495-501.
17. Yoshida S, Matsui M, Shirouzu Y, Fujita H, Yamana H, Shirouzu K. Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg 1998; 227: 485-91.
18. Wieder H A, Brucher B L, Zimmermann F et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004; 22: 900-8.
19. Brucher B L, Weber W, Bauer M et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography. Ann Surg 2001; 233: 300-9.
20. Flamen P, Van Cutsem E, Lerut A et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002; 13: 361-8.